| Detected | Trial | Change |
|---|---|---|
| 2026-07-29 | NCT04905693 Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease |
date change Primary completion pushed: 2026-06 -> 2029-12 |
| 2026-07-29 | NCT04905693 Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease |
date change Completion pushed: 2026-06 -> 2029-12 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05203510 | A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid… | Pulmonary Arterial Hypertension | Active, Not Recruiting |
| Phase 3 | |||
| NCT05943535 | Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive… | Progressive Pulmonary Fibrosis | Recruiting |
| NCT03683186 | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH… | PAH | Enrolling by Invitation |
| NCT04905693 | Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease | Idiopathic Pulmonary Fibrosis | Enrolling by Invitation |
| Phase 1/2 | |||
| NCT06878560 | Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD | ESRD (End-Stage Renal Disease) | Recruiting |
| NCT07224763 | Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With… | ESRD (End-Stage Renal Disease) | Recruiting |
| Not specified | |||
| NCT06388421 | DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated… | Pulmonary Hypertension Due to Lung Diseases and Hypoxia | Recruiting |
| NCT03045029 | ADAPT - A Patient Registry of the Real-world Use of Orenitram® | Pulmonary Arterial Hypertension | Active, Not Recruiting |